MetaADEDB 2.0 @ LMMD
Hyperplastic cholecystopathy
(UMLS:C0860020)
UMLS ID:
C0860020
MeSH ID:
N/A
Synonym(s)
1.
Hyperplastic cholecystopathy
Associated Drug(s)
NameNumber of ReportsReference(s)Data Source
1rofecoxibFAERS: 4US FAERS
2Fingolimod HydrochlorideFAERS: 2US FAERS
3Ortho EvraFAERS: 2US FAERS
4ValsartanFAERS: 2US FAERS
5AmoxicillinFAERS: 1US FAERS
6AtorvastatinFAERS: 1US FAERS
7BortezomibFAERS: 1OFFSIDES
US FAERS
8CitalopramFAERS: 1US FAERS
9Duloxetine HydrochlorideFAERS: 1US FAERS
10ExenatideFAERS: 1US FAERS
11NuvaRingFAERS: 1US FAERS
12Sitagliptin PhosphateFAERS: 1US FAERS
13lanreotideFAERS: 1US FAERS
14tegaserodFAERS: 1US FAERS
15telithromycinFAERS: 1OFFSIDES
US FAERS
16AcetaminophenOFFSIDES
17AspirinOFFSIDES
18EptifibatideOFFSIDES
19FentanylOFFSIDES
20LetrozoleOFFSIDES
21MercaptopurineOFFSIDES
22NitrofurantoinOFFSIDES
23PamidronateOFFSIDES
24PhentermineOFFSIDES
25Zoledronic AcidOFFSIDES
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120241

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.